Executive Vice President and Chief Medical Officer
Mirjam joined Ferring Pharmaceuticals as Senior Vice President for Global Development in 2018 and became Chief Science and Medical Officer in since 2020. She announced her retirement in March 2022 but continues to hold the role of Chief Medical Officer until a successor is appointed. She has responsibility for global value and access, global pharmacovigilance, and global medical affairs activities.
Mirjam has over 30 years’ global experience across research, medical, clinical development and portfolio management, and previously held senior leadership positions at MSD, Schering-Plough and Organon. Mirjam graduated as a medical doctor from Utrecht University in the Netherlands.
